MedTrace Logo

Optimal Stimulation Programming for Spinal Peripheral Neuromodulation

NCT02346383 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2021-03-16

Study results available
· View outcomes & findings →

Summary

To determine the best parameters with various leads to cover back and leg pain and provide best pain relief

Conditions

Interventions

DEVICE

preset program

Change to different present program using epidural and peripheral lead to cover pain

Sponsors & Collaborators

  • Abbott Medical Devices

    collaborator INDUSTRY

  • Carolinas Center for Advanced Management of Pain

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
22 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2016-05-31
Completion
2016-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02346383 on ClinicalTrials.gov